PeopleBio Co Ltd
304840
Company Profile
Business description
PeopleBio Co Ltd is a biotechnology company. The company is engaged in the business of developing diagnostic products for neurodegenerative diseases. The company's technology, Multimer Detection System (MDS), helps in detecting protein misfolding diseases like Alzheimer's disease, Parkinson's disease, and Creutzfeldt-Jakob's disease.
Contact
242 Pangyo-ro
6th Floor, PDC C-dong
Bundang-gu, Gyeonggi-do
Seongnam-si13487
KORT: +82 315267825
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
65
Stocks News & Analysis
stocks
Is this ASX share a long-term buy?
Current operating conditions are challenging but over the long-term prospects are better.
stocks
Why Guzman and Reece's share reversals have a lot in common
Investors must weigh exciting growth stories against competitive dynamics and the price they are being asked to pay.
stocks
Going into earnings, is Nvidia stock a buy, a sell, or fairly valued?
Watching the data centre business and the debate around it, here’s what we think of Nvidia stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,477.30 | 20.70 | -0.24% |
CAC 40 | 8,137.26 | 86.19 | 1.07% |
DAX 40 | 22,732.24 | 321.97 | 1.44% |
Dow JONES (US) | 43,758.96 | 137.80 | 0.32% |
FTSE 100 | 8,722.03 | 53.36 | 0.62% |
HKSE | 23,787.93 | 753.91 | 3.27% |
NASDAQ | 19,196.80 | 170.41 | 0.90% |
Nikkei 225 | 38,142.37 | 95.42 | -0.25% |
NZX 50 Index | 12,452.46 | 145.19 | 1.18% |
S&P 500 | 5,991.45 | 36.20 | 0.61% |
S&P/ASX 200 | 8,240.70 | 11.20 | -0.14% |
SSE Composite Index | 3,380.21 | 34.17 | 1.02% |